Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2018
Immunomodulatory effect of Arabinosylated lipoarabinomannan restrict the progression of visceral leishmaniasis through NOD2 inflammatory pathway: Functional regulation of T cell subsets.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Jawed Junaid Jibran, Banerjee Sayantan, Bandyopadhyay Syamdas, Parveen Shabina, Chowdhury Bidisha Paul, Saini Prasanta, Majumdar Subrata
Аннотация
NOD like receptors (NLR) are essential pathogen associated molecular pattern receptors of cytoplasmic origin. During several intracellular parasitic infections NLR played vital role for host protective immune response against the pathogen. Amongst various classes of NLR, NOD1 and NOD2 had been extensively studied and were found to be the most active member of the NLR family. Therefore, we wanted to study the role of NOD1/NOD2 during Leishmania donovani infection and the mechanism behind the utilization of this pathway as a therapeutic approach. Using the infected model of macrophage and BALB/c mice the expression of NOD1 and NOD2 were analysed. Our study showed that NOD2 but not NOD1 has been exploited during experimental VL, leading to the imbalance between Th-1/Th-2 cytokines profile. Over-expression of NOD2 and stimulation with its ligand muramyl dipeptide leads to successful clearance of parasite. During in vivo experiments we found that arabinosylated lipoarabinomannan helps in the restoration of NOD2 and with MDP in combination leads to effective clearance of parasite which rescued host protective immunity and comparatively more effective than Mw and MDP combination resulting in increase T cell response. Consequently, our study highlighted the significance of NOD2 during infection the immune-modulations of which can be used as a therapeutic target.
Предметные рубрики MeSH
AnimalsCytokinesDisease Models, AnimalHost-Pathogen InteractionsImmunity, InnateImmunologic FactorsInflammation MediatorsLeishmania donovaniLeishmaniasis, VisceralLipopolysaccharidesMice, Inbred BALB CNitric OxideNitric Oxide Synthase Type IINod1 Signaling Adaptor ProteinNod2 Signaling Adaptor ProteinParasite LoadSignal TransductionT-Lymphocyte SubsetsTh1-Th2 BalanceTrypanocidal Agents